Cost-effectiveness of an adherence-enhancing intervention for gout based on real-world data.

ABSTRACT:

Aim

Medication non-adherence influences outcomes of therapies for chronic diseases. Allopurinol is a cornerstone therapy for patients with gout; however, non-adherence to allopurinol is prevalent in Singapore and limits its effectiveness. Between 2008-2010, an adherence-enhancing program was implemented at the rheumatology division of a public tertiary hospital. The cost-effectiveness of this program has not been fully evaluated. With healthcare resources being finite, the value of investing in adherence-enhancing interventions should be ascertained. This study aims to evaluate the cost-effectiveness of this adherence-enhancing program to inform optimal resource allocation toward better gout management.

Method

Adopting a real-world data approach, we utilized patient clinical

SUBMITTER: Lin LW 

PROVIDER: S-EPMC6590285 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature